Telegraph Hill Partners
Telegraph Hill Partners, founded in 2001, is a venture capital firm focused on helping life science, medical device, and healthcare companies achieve their growth objectives. The firm partners with innovative companies by providing capital and strategic guidance to help them become world-class businesses. They focus on private life science and healthcare companies with novel technologies, a solid customer base, and innovative management teams.
Telegraph Hill Partners
300 Montgomery Street, Suite 1130, San Francisco, CA 94104
Portfolio
Quanterix is involved in ultra-sensitive biomarker detection, and it acquired Akoya Biosciences to create an integrated solution for protein biomarker detection.
#Biotechnology
Nimble Therapeutics is focused on oral peptide therapeutics and was acquired by AbbVie to strengthen its immunology pipeline.
#Biotechnology
Promptly Technology is a leader in streamlining patient engagement and received a strategic minority investment to accelerate its growth.
#Healthcare Technology
Althea Technologies was acquired by Ajinomoto Co., Inc. to expand into the contract development and manufacturing market.
#Biopharmaceutical Development and Manufacturing
Aquaro Histology completed a Series A funding round of $9.8 million led by Telegraph Hill Partners to launch its first product, the Aquaro ASM.
#Histology Technology